This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Working together with biotechs, the pharmaceutical industry and investors specialized in the biomedical sector (venture capital) is essential when converting knowledge produced at the CNIO into tangible technologies. At the same time, our researchers benefit from the experience and competitive edge they acquire when inter-acting with the business sector.
Among the companies we have partnered with are the following:
